BTZ has been found to inhibit the activity of fibroblasts and reduce pulmonary inflammation in a model of pulmonary fibrosis.[35] However, its role in other respiratory diseases including COPD and lung cancer has not been well investigated. Here, CASC3 is linked to lung carcinoma.